Neuren Pharmaceuticals Limited (NURPF)
Market Closed
10 Aug, 20:00
OTC PINK 
$
16. 00
+1
+6.6667%
$
1.12B Market Cap
- P/E Ratio
- Div Yield
4,450 Volume
- Eps
$ 15
Previous Close Want to track NURPF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
NURPF closed today higher at $16, an increase of 6.6667% from yesterday's close, completing a monthly increase of 18.8707% or $2.54. Over the past 12 months, NURPF stock gained 23.9714%.
NURPF is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Neuren Pharmaceuticals Limited has completed 1 stock splits, with the recent split occurring on Nov 21, 2017.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).
Neuren Pharmaceuticals Limited (NURPF) FAQ
What is the stock price today?
The current price is $16.00.
On which exchange is it traded?
Neuren Pharmaceuticals Limited is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is NURPF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.12B.
Has Neuren Pharmaceuticals Limited ever had a stock split?
Neuren Pharmaceuticals Limited had 1 splits and the recent split was on Nov 21, 2017.
Neuren Pharmaceuticals Limited Profile
| Biotechnology Industry | Healthcare Sector | - CEO | OTC PINK Exchange | NZNEUE0001S8 ISIN |
| Germany Country | - Employees | - Last Dividend | 21 Jun 2011 Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
